data_1svj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1svj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.265 0.555 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.498 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 83.6 mtm180 -123.12 143.52 49.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . 0.524 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.3 mt-30 -132.36 149.37 52.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.521 ' HB2' ' CD1' ' A' ' 355' ' ' LEU . . . -58.49 136.2 57.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.017 -1.052 . . . . 0.0 109.873 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' SER . . . . . 0.522 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 1.8 m -116.88 -31.83 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -170.83 147.08 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.096 -1.003 . . . . 0.0 110.063 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.648 ' CD1' ' CD2' ' A' ' 355' ' ' LEU . 13.9 p90 -134.43 142.48 47.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.776 -1.202 . . . . 0.0 111.662 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.469 HG23 ' HD2' ' A' ' 324' ' ' PRO . 6.4 mt -115.62 141.7 27.78 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.82 -0.55 . . . . 0.0 109.537 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.533 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.9 142.87 39.8 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.684 1.36 . . . . 0.0 111.446 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ALA . . . . . 0.595 ' HA ' ' CG2' ' A' ' 416' ' ' VAL . . . -70.97 152.38 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 108.736 165.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.76 128.51 37.58 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.667 -1.27 . . . . 0.0 110.134 -172.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.25 -0.65 43.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 324' ' ' PRO . 46.0 t -136.14 139.43 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.698 -1.472 . . . . 0.0 110.697 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.1 m-20 -73.89 151.84 40.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.33 -0.856 . . . . 0.0 110.097 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLU . . . . . 0.533 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.7 tt0 -61.72 -39.99 93.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 0.0 110.365 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.03 -43.35 91.59 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.74 -1.225 . . . . 0.0 109.624 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 329' ' ' ASP . 94.8 m -56.3 -43.74 79.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.804 173.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.55 ' CD1' ' CD1' ' A' ' 440' ' ' LEU . 5.0 tp -59.45 -39.74 84.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.323 -0.861 . . . . 0.0 110.334 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ALA . . . . . 0.537 ' HB2' ' CZ ' ' A' ' 322' ' ' PHE . . . -67.85 -41.31 83.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.088 . . . . 0.0 110.707 -176.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.3 m-20 -63.89 -50.04 70.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.868 -1.145 . . . . 0.0 109.912 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.6 ' CB ' ' CD2' ' A' ' 440' ' ' LEU . . . -67.21 -31.57 72.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.994 -1.067 . . . . 0.0 109.674 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ALA . . . . . 0.509 ' CB ' HD13 ' A' ' 443' ' ' ILE . . . -55.96 -35.19 66.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.259 -0.901 . . . . 0.0 109.085 173.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 363' ' ' ARG . 15.2 mt-30 -73.75 -56.08 5.43 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.474 -0.766 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.547 ' CD2' ' O ' ' A' ' 335' ' ' ASP . 0.0 OUTLIER -61.64 -36.27 80.3 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.756 -172.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 395' ' ' LYS . . . -67.49 -20.58 65.47 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 109.911 173.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . 0.456 ' OG ' HG21 ' A' ' 353' ' ' VAL . 96.3 p -106.7 8.84 31.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.476 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.5 mt -65.97 -44.73 84.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.558 -1.339 . . . . 0.0 109.64 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 374' ' ' PHE . . . -97.41 2.47 50.46 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.85 -170.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 344' ' ' ASP . 13.8 p30 -64.35 130.43 43.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 109.982 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.74 5.11 52.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.574 0.702 . . . . 0.0 109.896 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' THR . . . . . . . . . . . . . 2.6 p -76.39 150.26 82.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.546 -0.722 . . . . 0.0 109.473 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -53.89 -39.3 85.11 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.703 1.37 . . . . 0.0 109.165 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLU . . . . . 0.498 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 97.8 mt-10 -64.75 -28.45 69.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.594 -0.691 . . . . 0.0 110.516 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLY . . . . . 0.468 ' HA2' ' OD2' ' A' ' 344' ' ' ASP . . . -54.91 -36.21 59.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 354' ' ' ILE . 93.8 mtt180 -77.38 -38.33 50.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 110.668 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.524 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.6 m -61.07 -37.97 84.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.923 -1.11 . . . . 0.0 110.284 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 355' ' ' LEU . 82.7 mt -68.39 -48.87 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 110.621 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' VAL . . . . . 0.508 ' HA ' ' HG2' ' A' ' 338' ' ' GLN . 36.2 t -61.97 -33.86 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.201 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.464 HD13 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.98 -32.79 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.701 -1.249 . . . . 0.0 110.64 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' LEU . . . . . 0.648 ' CD2' ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.35 -40.86 87.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.998 -1.064 . . . . 0.0 110.398 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ALA . . . . . 0.429 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.5 -44.33 96.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.452 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.53 ' HB3' ' CD2' ' A' ' 362' ' ' LEU . 79.4 mttt -69.78 -46.47 65.7 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.917 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' GLN . . . . . 0.521 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.6 pt20 -71.55 -43.18 66.85 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.25 -0.907 . . . . 0.0 110.718 -172.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.572 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 71.9 mtt-85 -79.52 -41.88 26.38 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 111.855 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 359' ' ' ARG . 83.2 m-85 -134.83 -35.31 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.332 -1.48 . . . . 0.0 112.11 -168.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.474 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 58.5 t-20 -160.62 97.31 1.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.572 -1.33 . . . . 0.0 111.698 -169.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LEU . . . . . 0.53 ' CD2' ' HB3' ' A' ' 357' ' ' LYS . 27.3 mt -57.78 89.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.768 -1.207 . . . . 0.0 108.966 170.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.531 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -143.68 163.04 34.4 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 109.243 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -126.88 -151.41 0.48 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.981 -1.074 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' ARG . . . . . 0.598 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.1 ptt-85 -94.21 163.11 13.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.745 -0.597 . . . . 0.0 110.611 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.8 m-20 -123.46 38.68 4.14 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.328 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' VAL . . . . . 0.571 HG21 ' CE1' ' A' ' 374' ' ' PHE . 60.5 t -74.02 -46.37 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.407 -0.808 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.49 -27.48 66.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 111.096 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -30.62 29.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.702 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LEU . . . . . 0.523 ' CB ' HD12 ' A' ' 388' ' ' ILE . 22.4 mt -102.36 -3.75 26.62 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.535 -0.728 . . . . 0.0 110.656 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 78.2 t60 59.37 53.42 5.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.916 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 388' ' ' ILE . . . -94.19 174.55 7.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.439 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 30.3 m -117.18 134.83 54.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.837 . . . . 0.0 110.527 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' PHE . . . . . 0.571 ' CE1' HG21 ' A' ' 367' ' ' VAL . 75.4 m-85 -89.22 149.05 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 76.9 t -121.88 100.82 42.94 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 109.6 174.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -54.74 154.0 22.38 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.023 1.539 . . . . 0.0 110.475 -175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.5 t80 -70.17 134.47 48.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p -115.13 143.55 45.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.23 -23.65 59.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.714 -0.616 . . . . 0.0 110.328 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -61.77 -44.36 97.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 383' ' ' MET . 75.2 m -94.96 -13.6 25.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 110.205 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 381' ' ' SER . 72.7 mtt85 57.68 48.41 14.08 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' MET . . . . . 0.552 ' N ' ' CE2' ' A' ' 377' ' ' PHE . 4.9 ptp -165.31 170.66 14.43 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.843 0.83 . . . . 0.0 111.282 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' SER . . . . . 0.509 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.0 p -154.98 165.2 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.04 -166.81 35.6 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.736 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 367' ' ' VAL . 3.6 tt -140.34 149.59 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.618 -0.931 . . . . 0.0 110.196 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -127.49 136.49 51.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.695 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.544 ' CG2' ' HB2' ' A' ' 391' ' ' ARG . 1.7 tt -141.33 155.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 109.219 172.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 90.2 m-20 -22.76 -62.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.41 0.624 . . . . 0.0 112.532 171.611 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ASN . . . . . 0.442 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 35.8 t30 -96.77 -5.44 38.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 111.848 -167.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ARG . . . . . 0.544 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.2 mtp180 -144.58 144.58 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.686 -1.259 . . . . 0.0 110.374 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.1 mtt -134.21 109.15 8.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.921 -1.112 . . . . 0.0 108.934 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ILE . . . . . 0.523 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 8.2 mt -128.84 145.96 34.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.059 -1.026 . . . . 0.0 110.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 30.0 mtt180 -134.53 160.43 38.06 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 110.816 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.509 ' CE ' ' OG ' ' A' ' 384' ' ' SER . 0.0 OUTLIER -134.64 126.69 29.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -152.27 173.94 31.3 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.632 -173.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.2 m -55.92 149.67 14.69 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.85 -1.382 . . . . 0.0 108.405 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.528 ' CG2' HG11 ' A' ' 420' ' ' VAL . 19.3 t -55.5 -37.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.047 -1.033 . . . . 0.0 109.889 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -63.42 -43.55 97.13 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.302 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ALA . . . . . 0.516 ' CB ' ' HE1' ' A' ' 383' ' ' MET . . . -68.41 -50.54 52.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.916 -1.115 . . . . 0.0 110.653 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ILE . . . . . 0.522 HG23 ' CG1' ' A' ' 432' ' ' VAL . 38.2 mm -65.16 -43.59 95.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.972 -1.08 . . . . 0.0 110.841 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ARG . . . . . 0.587 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.5 ttp180 -59.57 -43.39 93.62 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 97.5 mtt180 -61.45 -36.73 81.23 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.027 -1.046 . . . . 0.0 109.543 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' HIS . . . . . 0.517 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.86 -38.27 82.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 111.35 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 437' ' ' SER . 69.3 t -66.08 -47.05 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.53 -1.356 . . . . 0.0 110.205 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.1 -34.45 78.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.878 -1.139 . . . . 0.0 110.412 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.39 80.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 109.871 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.517 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 23.2 m-80 -62.02 -27.43 68.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.787 . . . . 0.0 109.242 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.35 19.51 30.06 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -169.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.56 -171.22 18.33 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -145.31 153.93 41.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 111.185 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.587 ' CE2' ' HG3' ' A' ' 402' ' ' ARG . 8.3 p90 -109.37 151.28 42.02 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 109.991 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' PRO . . . . . 0.535 ' HG2' ' CB ' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.17 127.22 12.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.864 1.455 . . . . 0.0 110.461 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' THR . . . . . 0.457 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.4 t -67.07 -34.58 77.97 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 111.085 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -62.2 -33.29 74.28 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.894 -1.129 . . . . 0.0 108.851 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' VAL . . . . . 0.595 ' CG2' ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.54 -41.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.426 -0.796 . . . . 0.0 110.863 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' ASP . . . . . 0.491 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 58.1 t0 -55.25 -38.2 68.21 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.864 -1.148 . . . . 0.0 109.549 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 57.1 mt-30 -64.0 -48.19 77.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.398 -1.439 . . . . 0.0 110.359 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 415' ' ' ASP . 87.7 mttt -56.6 -35.13 67.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.687 -1.258 . . . . 0.0 110.278 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 442' ' ' VAL . 2.7 t -60.11 -41.2 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.964 -1.085 . . . . 0.0 109.399 171.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -65.57 -36.37 83.59 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.861 0.839 . . . . 0.0 109.293 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 418' ' ' GLN . 83.8 mt-30 -68.69 -36.42 78.47 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.678 -0.639 . . . . 0.0 110.523 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' VAL . . . . . 0.469 HG13 ' HB1' ' A' ' 428' ' ' ALA . 64.4 t -62.35 -37.38 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.902 -1.124 . . . . 0.0 109.908 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.84 -44.7 76.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.622 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 6.8 ptm180 -69.69 -26.32 64.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.809 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -84.01 -4.76 58.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -0.972 . . . . 0.0 109.757 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.35 21.24 27.66 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . 0.469 ' HB1' HG13 ' A' ' 423' ' ' VAL . . . -107.19 163.4 13.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.107 . . . . 0.0 109.554 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' THR . . . . . 0.47 ' O ' HD11 ' A' ' 445' ' ' LEU . 34.4 m -110.58 106.91 58.13 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.807 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' PRO . . . . . 0.507 ' CB ' HG12 ' A' ' 420' ' ' VAL . 37.3 Cg_endo -75.47 107.9 2.58 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.951 1.5 . . . . 0.0 110.586 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.541 ' HG ' ' CD1' ' A' ' 445' ' ' LEU . 12.4 mt -92.0 133.76 35.42 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.859 -1.151 . . . . 0.0 108.482 166.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.525 ' CG1' HG12 ' A' ' 439' ' ' VAL . 90.5 t -99.17 134.4 38.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.715 -1.241 . . . . 0.0 109.389 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' VAL . . . . . 0.483 ' O ' HD12 ' A' ' 440' ' ' LEU . 34.9 t -115.1 137.77 47.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.96 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' ' 439' ' ' VAL . 2.9 m -122.01 160.07 24.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . 0.488 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -135.7 133.15 37.79 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.92 -124.82 26.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' SER . . . . . 0.485 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 1.0 OUTLIER -111.45 11.96 21.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.263 . . . . 0.0 111.109 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -125.58 171.04 10.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.562 -1.336 . . . . 0.0 110.111 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . 0.525 HG12 ' CG1' ' A' ' 432' ' ' VAL . 56.4 t -89.5 134.24 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.877 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.6 ' CD2' ' CB ' ' A' ' 336' ' ' ALA . 1.2 pp -93.35 -21.87 19.29 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.6 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.553 ' HA2' ' N ' ' A' ' 325' ' ' ALA . . . 170.06 176.7 39.86 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.959 169.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 420' ' ' VAL . 47.4 t -107.86 141.7 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.055 -1.262 . . . . 0.0 109.802 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 337' ' ' ALA . 81.0 mt -101.39 110.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ALA . . . . . 0.466 ' HB1' HG22 ' A' ' 423' ' ' VAL . . . -91.58 118.85 30.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.998 -1.064 . . . . 0.0 109.739 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LEU . . . . . 0.541 ' CD1' ' HG ' ' A' ' 431' ' ' LEU . 1.1 mt -100.45 143.85 30.15 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . 0.454 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 58.3 mttt -120.63 161.36 21.5 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.708 -1.245 . . . . 0.0 111.24 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.6 148.93 25.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.817 -0.552 . . . . 0.0 110.246 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ILE . . . . . 0.454 HG21 ' HE3' ' A' ' 450' ' ' LYS . 10.7 tp -115.87 153.91 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.124 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.39 134.06 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.359 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.454 ' HE3' HG21 ' A' ' 448' ' ' ILE . 84.7 mttt -143.42 146.5 33.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 110.105 175.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.582 -179.938 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.265 0.555 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.498 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 83.6 mtm180 -123.12 143.52 49.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.3 mt-30 -132.36 149.37 52.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.902 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.49 136.2 57.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.017 -1.052 . . . . 0.0 109.873 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' SER . . . . . 0.522 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 1.8 m -116.88 -31.83 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -170.83 147.08 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.096 -1.003 . . . . 0.0 110.063 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 1.129 ' CD1' HD21 ' A' ' 355' ' ' LEU . 13.9 p90 -134.43 142.48 47.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.776 -1.202 . . . . 0.0 111.662 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.646 HG21 ' CD ' ' A' ' 419' ' ' LYS . 6.4 mt -115.62 141.7 27.78 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.82 -0.55 . . . . 0.0 109.537 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.9 142.87 39.8 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.684 1.36 . . . . 0.0 111.446 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ALA . . . . . 1.1 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.97 152.38 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 108.736 165.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.4 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 10.7 tp60 -58.76 128.51 37.58 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.667 -1.27 . . . . 0.0 110.134 -172.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.25 -0.65 43.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.0 t -136.14 139.43 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.698 -1.472 . . . . 0.0 110.697 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ASP . . . . . 0.463 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.1 m-20 -73.89 151.84 40.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.33 -0.856 . . . . 0.0 110.097 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.7 tt0 -61.72 -39.99 93.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 0.0 110.365 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.03 -43.35 91.59 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.74 -1.225 . . . . 0.0 109.624 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' THR . . . . . 0.532 HG21 HG13 ' A' ' 328' ' ' VAL . 94.8 m -56.3 -43.74 79.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.804 173.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 1.003 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.0 tp -59.45 -39.74 84.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.323 -0.861 . . . . 0.0 110.334 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.85 -41.31 83.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.088 . . . . 0.0 110.707 -176.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.3 m-20 -63.89 -50.04 70.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.868 -1.145 . . . . 0.0 109.912 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.905 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.21 -31.57 72.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.994 -1.067 . . . . 0.0 109.674 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ALA . . . . . 0.677 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.96 -35.19 66.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.259 -0.901 . . . . 0.0 109.085 173.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLN . . . . . 0.539 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.2 mt-30 -73.75 -56.08 5.43 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.474 -0.766 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.64 -36.27 80.3 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.756 -172.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ALA . . . . . 0.411 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.49 -20.58 65.47 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 109.911 173.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . 0.615 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.3 p -106.7 8.84 31.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.476 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.5 mt -65.97 -44.73 84.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.558 -1.339 . . . . 0.0 109.64 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.41 2.47 50.46 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.85 -170.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ASP . . . . . 0.484 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.8 p30 -64.35 130.43 43.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 109.982 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.74 5.11 52.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.574 0.702 . . . . 0.0 109.896 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 346' ' ' THR . 2.6 p -76.39 150.26 82.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.546 -0.722 . . . . 0.0 109.473 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -53.89 -39.3 85.11 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.703 1.37 . . . . 0.0 109.165 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLU . . . . . 0.498 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 97.8 mt-10 -64.75 -28.45 69.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.594 -0.691 . . . . 0.0 110.516 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.91 -36.21 59.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.492 ' O ' HD12 ' A' ' 354' ' ' ILE . 93.8 mtt180 -77.38 -38.33 50.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 110.668 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.544 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.6 m -61.07 -37.97 84.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.923 -1.11 . . . . 0.0 110.284 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.536 HG23 HD13 ' A' ' 443' ' ' ILE . 82.7 mt -68.39 -48.87 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 110.621 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' VAL . . . . . 0.615 HG22 ' OG ' ' A' ' 341' ' ' SER . 36.2 t -61.97 -33.86 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.201 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.98 -32.79 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.701 -1.249 . . . . 0.0 110.64 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' LEU . . . . . 1.129 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.35 -40.86 87.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.998 -1.064 . . . . 0.0 110.398 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ALA . . . . . 0.441 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.5 -44.33 96.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.452 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 1.005 ' HB3' HD23 ' A' ' 362' ' ' LEU . 79.4 mttt -69.78 -46.47 65.7 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.917 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' GLN . . . . . 0.521 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.6 pt20 -71.55 -43.18 66.85 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.25 -0.907 . . . . 0.0 110.718 -172.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.596 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 71.9 mtt-85 -79.52 -41.88 26.38 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 111.855 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' PHE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 359' ' ' ARG . 83.2 m-85 -134.83 -35.31 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.332 -1.48 . . . . 0.0 112.11 -168.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 58.5 t-20 -160.62 97.31 1.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.572 -1.33 . . . . 0.0 111.698 -169.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LEU . . . . . 1.005 HD23 ' HB3' ' A' ' 357' ' ' LYS . 27.3 mt -57.78 89.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.768 -1.207 . . . . 0.0 108.966 170.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.531 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -143.68 163.04 34.4 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 109.243 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -126.88 -151.41 0.48 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.981 -1.074 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' ARG . . . . . 0.598 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.1 ptt-85 -94.21 163.11 13.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.745 -0.597 . . . . 0.0 110.611 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.8 m-20 -123.46 38.68 4.14 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.328 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' VAL . . . . . 0.966 HG11 ' CE2' ' A' ' 374' ' ' PHE . 60.5 t -74.02 -46.37 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.407 -0.808 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.49 -27.48 66.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 111.096 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -30.62 29.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.702 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LEU . . . . . 0.765 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.4 mt -102.36 -3.75 26.62 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.535 -0.728 . . . . 0.0 110.656 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 78.2 t60 59.37 53.42 5.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.916 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.19 174.55 7.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.439 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 30.3 m -117.18 134.83 54.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.837 . . . . 0.0 110.527 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' PHE . . . . . 0.966 ' CE2' HG11 ' A' ' 367' ' ' VAL . 75.4 m-85 -89.22 149.05 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 76.9 t -121.88 100.82 42.94 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 109.6 174.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.4 Cg_endo -54.74 154.0 22.38 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.023 1.539 . . . . 0.0 110.475 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.5 t80 -70.17 134.47 48.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p -115.13 143.55 45.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.23 -23.65 59.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.714 -0.616 . . . . 0.0 110.328 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -61.77 -44.36 97.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 383' ' ' MET . 75.2 m -94.96 -13.6 25.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 110.205 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ARG . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 72.7 mtt85 57.68 48.41 14.08 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' MET . . . . . 1.011 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.9 ptp -165.31 170.66 14.43 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.843 0.83 . . . . 0.0 111.282 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' SER . . . . . 0.53 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.0 p -154.98 165.2 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.04 -166.81 35.6 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.736 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ILE . . . . . 0.904 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.6 tt -140.34 149.59 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.618 -0.931 . . . . 0.0 110.196 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -127.49 136.49 51.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.695 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -141.33 155.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 109.219 172.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 90.2 m-20 -22.76 -62.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.41 0.624 . . . . 0.0 112.532 171.611 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 35.8 t30 -96.77 -5.44 38.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 111.848 -167.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ARG . . . . . 0.555 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.2 mtp180 -144.58 144.58 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.686 -1.259 . . . . 0.0 110.374 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.1 mtt -134.21 109.15 8.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.921 -1.112 . . . . 0.0 108.934 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ILE . . . . . 1.036 HD12 HD11 ' A' ' 339' ' ' LEU . 8.2 mt -128.84 145.96 34.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.059 -1.026 . . . . 0.0 110.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 30.0 mtt180 -134.53 160.43 38.06 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 110.816 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.549 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.64 126.69 29.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.605 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.27 173.94 31.3 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.632 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.2 m -55.92 149.67 14.69 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.85 -1.382 . . . . 0.0 108.405 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.999 HG21 ' CG1' ' A' ' 420' ' ' VAL . 19.3 t -55.5 -37.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.047 -1.033 . . . . 0.0 109.889 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -63.42 -43.55 97.13 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.302 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ALA . . . . . 1.011 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.41 -50.54 52.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.916 -1.115 . . . . 0.0 110.653 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ILE . . . . . 0.605 HD11 ' N ' ' A' ' 396' ' ' GLY . 38.2 mm -65.16 -43.59 95.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.972 -1.08 . . . . 0.0 110.841 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.5 ttp180 -59.57 -43.39 93.62 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 97.5 mtt180 -61.45 -36.73 81.23 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.027 -1.046 . . . . 0.0 109.543 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' HIS . . . . . 0.517 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.86 -38.27 82.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 111.35 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' VAL . . . . . 0.475 HG12 ' C ' ' A' ' 410' ' ' GLY . 69.3 t -66.08 -47.05 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.53 -1.356 . . . . 0.0 110.205 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.1 -34.45 78.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.878 -1.139 . . . . 0.0 110.412 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.39 80.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 109.871 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.517 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 23.2 m-80 -62.02 -27.43 68.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.787 . . . . 0.0 109.242 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.35 19.51 30.06 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -169.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.56 -171.22 18.33 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -145.31 153.93 41.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 111.185 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.605 ' HB3' HG21 ' A' ' 439' ' ' VAL . 8.3 p90 -109.37 151.28 42.02 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 109.991 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' PRO . . . . . 0.863 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.17 127.22 12.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.864 1.455 . . . . 0.0 110.461 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.4 t -67.07 -34.58 77.97 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 111.085 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -62.2 -33.29 74.28 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.894 -1.129 . . . . 0.0 108.851 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' VAL . . . . . 1.1 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.54 -41.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.426 -0.796 . . . . 0.0 110.863 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 58.1 t0 -55.25 -38.2 68.21 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.864 -1.148 . . . . 0.0 109.549 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 57.1 mt-30 -64.0 -48.19 77.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.398 -1.439 . . . . 0.0 110.359 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LYS . . . . . 0.646 ' CD ' HG21 ' A' ' 323' ' ' ILE . 87.7 mttt -56.6 -35.13 67.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.687 -1.258 . . . . 0.0 110.278 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' VAL . . . . . 1.032 HG23 HG21 ' A' ' 442' ' ' VAL . 2.7 t -60.11 -41.2 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.964 -1.085 . . . . 0.0 109.399 171.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -65.57 -36.37 83.59 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.861 0.839 . . . . 0.0 109.293 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 425' ' ' ARG . 83.8 mt-30 -68.69 -36.42 78.47 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.678 -0.639 . . . . 0.0 110.523 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 428' ' ' ALA . 64.4 t -62.35 -37.38 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.902 -1.124 . . . . 0.0 109.908 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.84 -44.7 76.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.622 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 6.8 ptm180 -69.69 -26.32 64.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.809 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -84.01 -4.76 58.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -0.972 . . . . 0.0 109.757 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.35 21.24 27.66 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ALA . . . . . 0.691 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.19 163.4 13.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.107 . . . . 0.0 109.554 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.674 ' HB ' HD12 ' A' ' 445' ' ' LEU . 34.4 m -110.58 106.91 58.13 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.807 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' PRO . . . . . 0.545 ' CG ' HG13 ' A' ' 420' ' ' VAL . 37.3 Cg_endo -75.47 107.9 2.58 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.951 1.5 . . . . 0.0 110.586 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.4 mt -92.0 133.76 35.42 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.859 -1.151 . . . . 0.0 108.482 166.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.964 ' CG2' HG22 ' A' ' 398' ' ' VAL . 90.5 t -99.17 134.4 38.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.715 -1.241 . . . . 0.0 109.389 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' VAL . . . . . 0.925 ' CG1' HD11 ' A' ' 440' ' ' LEU . 34.9 t -115.1 137.77 47.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.96 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.9 m -122.01 160.07 24.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLU . . . . . 0.478 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -135.7 133.15 37.79 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.92 -124.82 26.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 1.0 OUTLIER -111.45 11.96 21.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.263 . . . . 0.0 111.109 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -125.58 171.04 10.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.562 -1.336 . . . . 0.0 110.111 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . 0.85 ' HA ' HG12 ' A' ' 434' ' ' VAL . 56.4 t -89.5 134.24 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.877 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.925 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -93.35 -21.87 19.29 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.6 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 1.003 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.06 176.7 39.86 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.959 169.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 1.032 HG21 HG23 ' A' ' 420' ' ' VAL . 47.4 t -107.86 141.7 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.055 -1.262 . . . . 0.0 109.802 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.677 HD11 ' HB1' ' A' ' 337' ' ' ALA . 81.0 mt -101.39 110.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ALA . . . . . 0.606 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.58 118.85 30.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.998 -1.064 . . . . 0.0 109.739 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LEU . . . . . 0.878 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.1 mt -100.45 143.85 30.15 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LYS . . . . . 0.454 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 58.3 mttt -120.63 161.36 21.5 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.708 -1.245 . . . . 0.0 111.24 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.6 148.93 25.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.817 -0.552 . . . . 0.0 110.246 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.7 tp -115.87 153.91 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.124 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.39 134.06 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.359 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -143.42 146.5 33.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 110.105 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.582 -179.938 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.265 0.555 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.498 ' NE ' ' OE2' ' A' ' 348' ' ' GLU . 83.6 mtm180 -123.12 143.52 49.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.202 -0.936 . . . . 0.0 110.145 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 351' ' ' SER . 91.3 mt-30 -132.36 149.37 52.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 0.0 110.147 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.902 ' HB1' HD13 ' A' ' 355' ' ' LEU . . . -58.49 136.2 57.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.017 -1.052 . . . . 0.0 109.873 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' SER . . . . . 0.522 ' O ' ' CZ ' ' A' ' 359' ' ' ARG . 1.8 m -116.88 -31.83 5.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.177 -0.952 . . . . 0.0 110.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -170.83 147.08 2.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.096 -1.003 . . . . 0.0 110.063 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 1.129 ' CD1' HD21 ' A' ' 355' ' ' LEU . 13.9 p90 -134.43 142.48 47.14 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.776 -1.202 . . . . 0.0 111.662 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.646 HG21 ' CD ' ' A' ' 419' ' ' LYS . 6.4 mt -115.62 141.7 27.78 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.82 -0.55 . . . . 0.0 109.537 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.551 ' HG3' ' N ' ' A' ' 330' ' ' GLU . 3.0 Cg_exo -71.9 142.87 39.8 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.684 1.36 . . . . 0.0 111.446 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ALA . . . . . 1.1 ' HA ' HG21 ' A' ' 416' ' ' VAL . . . -70.97 152.38 43.67 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 108.736 165.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.4 ' H ' ' CG ' ' A' ' 413' ' ' PRO . 0.6 OUTLIER -58.76 128.51 37.58 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.667 -1.27 . . . . 0.0 110.134 -172.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . 104.25 -0.65 43.78 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 440' ' ' LEU . 46.0 t -136.14 139.43 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.698 -1.472 . . . . 0.0 110.697 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ASP . . . . . 0.463 ' O ' ' HB ' ' A' ' 332' ' ' THR . 88.1 m-20 -73.89 151.84 40.33 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.33 -0.856 . . . . 0.0 110.097 177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 324' ' ' PRO . 84.7 tt0 -61.72 -39.99 93.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 0.0 110.365 -176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -59.03 -43.35 91.59 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.74 -1.225 . . . . 0.0 109.624 175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . 0.532 HG21 HG13 ' A' ' 328' ' ' VAL . 94.8 m -56.3 -43.74 79.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.804 173.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 1.003 HD22 ' HA3' ' A' ' 441' ' ' GLY . 5.0 tp -59.45 -39.74 84.6 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.323 -0.861 . . . . 0.0 110.334 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ALA . . . . . 0.972 ' HB2' ' CE2' ' A' ' 322' ' ' PHE . . . -67.85 -41.31 83.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.088 . . . . 0.0 110.707 -176.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 339' ' ' LEU . 90.3 m-20 -63.89 -50.04 70.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.868 -1.145 . . . . 0.0 109.912 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.905 ' HB1' HD13 ' A' ' 393' ' ' ILE . . . -67.21 -31.57 72.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.994 -1.067 . . . . 0.0 109.674 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ALA . . . . . 0.677 ' HB1' HD11 ' A' ' 443' ' ' ILE . . . -55.96 -35.19 66.41 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.259 -0.901 . . . . 0.0 109.085 173.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLN . . . . . 0.539 ' HG2' ' HA ' ' A' ' 353' ' ' VAL . 15.2 mt-30 -73.75 -56.08 5.43 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.474 -0.766 . . . . 0.0 110.908 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 1.036 HD11 HD12 ' A' ' 393' ' ' ILE . 0.0 OUTLIER -61.64 -36.27 80.3 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.756 -172.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ALA . . . . . 0.411 ' HA ' ' HA2' ' A' ' 385' ' ' GLY . . . -67.49 -20.58 65.47 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.158 -0.964 . . . . 0.0 109.911 173.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . 0.615 ' OG ' HG22 ' A' ' 353' ' ' VAL . 96.3 p -106.7 8.84 31.23 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.174 -0.954 . . . . 0.0 111.476 -175.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' LEU . . . . . 0.598 ' CD1' ' CB ' ' A' ' 365' ' ' ARG . 40.5 mt -65.97 -44.73 84.04 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.558 -1.339 . . . . 0.0 109.64 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 374' ' ' PHE . . . -97.41 2.47 50.46 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.85 -170.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ASP . . . . . 0.484 ' OD2' ' HA2' ' A' ' 349' ' ' GLY . 13.8 p30 -64.35 130.43 43.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.759 -1.213 . . . . 0.0 109.982 175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -95.74 5.11 52.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.574 0.702 . . . . 0.0 109.896 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 346' ' ' THR . 2.6 p -76.39 150.26 82.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.546 -0.722 . . . . 0.0 109.473 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -53.89 -39.3 85.11 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.703 1.37 . . . . 0.0 109.165 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLU . . . . . 0.498 ' OE2' ' NE ' ' A' ' 317' ' ' ARG . 97.8 mt-10 -64.75 -28.45 69.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.594 -0.691 . . . . 0.0 110.516 176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 353' ' ' VAL . . . -54.91 -36.21 59.93 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.492 ' O ' HD12 ' A' ' 354' ' ' ILE . 93.8 mtt180 -77.38 -38.33 50.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 110.668 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.544 ' CB ' ' HA ' ' A' ' 318' ' ' GLN . 5.6 m -61.07 -37.97 84.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.923 -1.11 . . . . 0.0 110.284 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.536 HG23 HD13 ' A' ' 443' ' ' ILE . 82.7 mt -68.39 -48.87 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 110.621 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' VAL . . . . . 0.615 HG22 ' OG ' ' A' ' 341' ' ' SER . 36.2 t -61.97 -33.86 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.915 -1.116 . . . . 0.0 110.201 -178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 350' ' ' ARG . 32.1 mt -72.98 -32.79 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.701 -1.249 . . . . 0.0 110.64 171.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' LEU . . . . . 1.129 HD21 ' CD1' ' A' ' 322' ' ' PHE . 0.3 OUTLIER -59.35 -40.86 87.76 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.998 -1.064 . . . . 0.0 110.398 178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ALA . . . . . 0.441 ' CB ' ' HG3' ' A' ' 338' ' ' GLN . . . -62.5 -44.33 96.64 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.426 -0.796 . . . . 0.0 110.452 177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 1.005 ' HB3' HD23 ' A' ' 362' ' ' LEU . 79.4 mttt -69.78 -46.47 65.7 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.917 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' GLN . . . . . 0.521 ' CG ' ' N ' ' A' ' 359' ' ' ARG . 13.6 pt20 -71.55 -43.18 66.85 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.25 -0.907 . . . . 0.0 110.718 -172.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.596 ' HB3' ' CD1' ' A' ' 360' ' ' PHE . 71.9 mtt-85 -79.52 -41.88 26.38 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 111.855 -171.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' PHE . . . . . 0.596 ' CD1' ' HB3' ' A' ' 359' ' ' ARG . 83.2 m-85 -134.83 -35.31 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.332 -1.48 . . . . 0.0 112.11 -168.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.51 ' C ' ' HA ' ' A' ' 357' ' ' LYS . 58.5 t-20 -160.62 97.31 1.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.572 -1.33 . . . . 0.0 111.698 -169.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LEU . . . . . 1.005 HD23 ' HB3' ' A' ' 357' ' ' LYS . 27.3 mt -57.78 89.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.768 -1.207 . . . . 0.0 108.966 170.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.531 ' O ' ' NE2' ' A' ' 338' ' ' GLN . 17.5 tpt180 -143.68 163.04 34.4 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.388 -0.82 . . . . 0.0 109.243 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 83.9 mt-10 -126.88 -151.41 0.48 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.981 -1.074 . . . . 0.0 110.486 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' ARG . . . . . 0.598 ' CB ' ' CD1' ' A' ' 342' ' ' LEU . 34.1 ptt-85 -94.21 163.11 13.58 Favored 'General case' 0 C--N 1.293 -1.864 0 O-C-N 121.745 -0.597 . . . . 0.0 110.611 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASP . . . . . 0.475 ' O ' ' HG ' ' A' ' 370' ' ' LEU . 88.8 m-20 -123.46 38.68 4.14 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.328 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' VAL . . . . . 0.966 HG11 ' CE2' ' A' ' 374' ' ' PHE . 60.5 t -74.02 -46.37 45.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.407 -0.808 . . . . 0.0 110.209 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -68.49 -27.48 66.17 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 111.096 -175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -30.62 29.09 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.112 -0.993 . . . . 0.0 109.702 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LEU . . . . . 0.765 ' HB3' HD11 ' A' ' 388' ' ' ILE . 22.4 mt -102.36 -3.75 26.62 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.535 -0.728 . . . . 0.0 110.656 -177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' HIS . . . . . 0.516 ' N ' ' O ' ' A' ' 367' ' ' VAL . 78.2 t60 59.37 53.42 5.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.0 109.916 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . 0.794 ' HB3' HG13 ' A' ' 367' ' ' VAL . . . -94.19 174.55 7.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.379 -0.825 . . . . 0.0 110.439 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' THR . . . . . . . . . . . . . 30.3 m -117.18 134.83 54.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.837 . . . . 0.0 110.527 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' PHE . . . . . 0.966 ' CE2' HG11 ' A' ' 367' ' ' VAL . 75.4 m-85 -89.22 149.05 23.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.0 109.627 174.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 385' ' ' GLY . 76.9 t -121.88 100.82 42.94 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.179 -0.95 . . . . 0.0 109.6 174.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 375' ' ' VAL . 7.4 Cg_endo -54.74 154.0 22.38 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.023 1.539 . . . . 0.0 110.475 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' PHE . . . . . 0.552 ' CE2' ' N ' ' A' ' 383' ' ' MET . 54.5 t80 -70.17 134.47 48.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.0 110.434 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' THR . . . . . . . . . . . . . 7.6 p -115.13 143.55 45.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . . . . . . . . . . . -74.23 -23.65 59.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.714 -0.616 . . . . 0.0 110.328 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -61.77 -44.36 97.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.18 -0.95 . . . . 0.0 109.722 -178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . 0.486 ' O ' ' HG2' ' A' ' 383' ' ' MET . 75.2 m -94.96 -13.6 25.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 110.205 176.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ARG . . . . . 0.526 ' HA ' ' CZ ' ' A' ' 377' ' ' PHE . 72.7 mtt85 57.68 48.41 14.08 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.57 -0.706 . . . . 0.0 109.707 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' MET . . . . . 1.011 ' HE3' ' HB1' ' A' ' 400' ' ' ALA . 4.9 ptp -165.31 170.66 14.43 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.843 0.83 . . . . 0.0 111.282 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' SER . . . . . 0.53 ' HB3' ' CB ' ' A' ' 377' ' ' PHE . 49.0 p -154.98 165.2 37.47 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 394' ' ' ARG . . . -179.04 -166.81 35.6 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 118.84 -1.648 . . . . 0.0 110.736 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ILE . . . . . 0.904 HG21 ' HB2' ' A' ' 339' ' ' LEU . 3.6 tt -140.34 149.59 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.618 -0.931 . . . . 0.0 110.196 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ASN . . . . . 0.454 HD21 HG21 ' A' ' 375' ' ' VAL . 36.1 m-20 -127.49 136.49 51.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.695 177.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.765 HD11 ' HB3' ' A' ' 370' ' ' LEU . 1.7 tt -141.33 155.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 109.219 172.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASP . . . . . 0.499 ' C ' ' O ' ' A' ' 388' ' ' ILE 0.267 90.2 m-20 -22.76 -62.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.41 0.624 . . . . 0.0 112.532 171.611 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ASN . . . . . 0.448 ' C ' ' HG3' ' A' ' 391' ' ' ARG . 35.8 t30 -96.77 -5.44 38.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 0.0 111.848 -167.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ARG . . . . . 0.555 ' HB2' ' CG2' ' A' ' 388' ' ' ILE . 29.2 mtp180 -144.58 144.58 31.36 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.686 -1.259 . . . . 0.0 110.374 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' MET . . . . . . . . . . . . . 63.1 mtt -134.21 109.15 8.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.921 -1.112 . . . . 0.0 108.934 169.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ILE . . . . . 1.036 HD12 HD11 ' A' ' 339' ' ' LEU . 8.2 mt -128.84 145.96 34.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.059 -1.026 . . . . 0.0 110.123 -175.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 433' ' ' VAL . 30.0 mtt180 -134.53 160.43 38.06 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.054 -1.029 . . . . 0.0 110.816 175.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.549 ' CB ' HG22 ' A' ' 433' ' ' VAL . 0.0 OUTLIER -134.64 126.69 29.66 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 174.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.605 ' N ' HD11 ' A' ' 401' ' ' ILE . . . -152.27 173.94 31.3 Favored Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.291 -1.433 . . . . 0.0 109.632 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' SER . . . . . . . . . . . . . 37.2 m -55.92 149.67 14.69 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.85 -1.382 . . . . 0.0 108.405 169.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.999 HG21 ' CG1' ' A' ' 420' ' ' VAL . 19.3 t -55.5 -37.46 45.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.047 -1.033 . . . . 0.0 109.889 -177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.457 ' O ' ' HG3' ' A' ' 403' ' ' ARG . 92.3 m-20 -63.42 -43.55 97.13 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.302 177.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ALA . . . . . 1.011 ' HB1' ' HE3' ' A' ' 383' ' ' MET . . . -68.41 -50.54 52.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.916 -1.115 . . . . 0.0 110.653 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ILE . . . . . 0.605 HD11 ' N ' ' A' ' 396' ' ' GLY . 38.2 mm -65.16 -43.59 95.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 120.972 -1.08 . . . . 0.0 110.841 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ARG . . . . . 0.586 ' HG3' ' CE2' ' A' ' 412' ' ' PHE . 10.5 ttp180 -59.57 -43.39 93.62 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.31 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' A' ' 399' ' ' ASP . 97.5 mtt180 -61.45 -36.73 81.23 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.027 -1.046 . . . . 0.0 109.543 172.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' HIS . . . . . 0.517 ' CE1' ' ND2' ' A' ' 408' ' ' ASN . 2.9 t-80 -67.86 -38.27 82.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 111.35 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' VAL . . . . . 0.475 HG12 ' C ' ' A' ' 410' ' ' GLY . 69.3 t -66.08 -47.05 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.53 -1.356 . . . . 0.0 110.205 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.1 -34.45 78.08 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.878 -1.139 . . . . 0.0 110.412 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' ALA . . . . . . . . . . . . . . . -67.61 -36.39 80.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.946 -1.096 . . . . 0.0 109.871 177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.517 ' ND2' ' CE1' ' A' ' 404' ' ' HIS . 23.2 m-80 -62.02 -27.43 68.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.44 -0.787 . . . . 0.0 109.242 173.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' GLY . . . . . . . . . . . . . . . 95.35 19.51 30.06 Favored Glycine 0 N--CA 1.483 1.787 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -169.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 437' ' ' SER . . . -112.56 -171.22 18.33 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -145.31 153.93 41.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.162 -1.199 . . . . 0.0 111.185 -174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.605 ' HB3' HG21 ' A' ' 439' ' ' VAL . 8.3 p90 -109.37 151.28 42.02 Favored Pre-proline 0 N--CA 1.5 2.037 0 O-C-N 121.478 -0.764 . . . . 0.0 109.991 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' PRO . . . . . 0.863 ' CG ' ' HB1' ' A' ' 325' ' ' ALA . 2.8 Cg_endo -72.17 127.22 12.51 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.864 1.455 . . . . 0.0 110.461 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 418' ' ' GLN . 1.4 t -67.07 -34.58 77.97 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 111.085 -177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 419' ' ' LYS . 90.4 m-20 -62.2 -33.29 74.28 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.894 -1.129 . . . . 0.0 108.851 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' VAL . . . . . 1.1 HG21 ' HA ' ' A' ' 325' ' ' ALA . 52.6 t -83.54 -41.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.426 -0.796 . . . . 0.0 110.863 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' ASP . . . . . 0.509 ' O ' ' HB ' ' A' ' 420' ' ' VAL . 58.1 t0 -55.25 -38.2 68.21 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.864 -1.148 . . . . 0.0 109.549 172.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 422' ' ' GLN . 57.1 mt-30 -64.0 -48.19 77.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.398 -1.439 . . . . 0.0 110.359 172.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LYS . . . . . 0.646 ' CD ' HG21 ' A' ' 323' ' ' ILE . 87.7 mttt -56.6 -35.13 67.91 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.687 -1.258 . . . . 0.0 110.278 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' VAL . . . . . 1.032 HG23 HG21 ' A' ' 442' ' ' VAL . 2.7 t -60.11 -41.2 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.964 -1.085 . . . . 0.0 109.399 171.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -65.57 -36.37 83.59 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.861 0.839 . . . . 0.0 109.293 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' GLN . . . . . 0.487 ' O ' ' HG2' ' A' ' 425' ' ' ARG . 83.8 mt-30 -68.69 -36.42 78.47 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.678 -0.639 . . . . 0.0 110.523 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' VAL . . . . . 0.691 HG13 ' HB3' ' A' ' 428' ' ' ALA . 64.4 t -62.35 -37.38 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.902 -1.124 . . . . 0.0 109.908 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ALA . . . . . . . . . . . . . . . -67.84 -44.7 76.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.622 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 422' ' ' GLN . 6.8 ptm180 -69.69 -26.32 64.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.0 -1.062 . . . . 0.0 110.809 -174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 426' ' ' GLN . 2.0 tt0 -84.01 -4.76 58.97 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -0.972 . . . . 0.0 109.757 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' GLY . . . . . . . . . . . . . . . 94.35 21.24 27.66 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . 0.691 ' HB3' HG13 ' A' ' 423' ' ' VAL . . . -107.19 163.4 13.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -1.107 . . . . 0.0 109.554 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.674 ' HB ' HD12 ' A' ' 445' ' ' LEU . 34.4 m -110.58 106.91 58.13 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.031 -1.043 . . . . 0.0 109.807 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' PRO . . . . . 0.545 ' CG ' HG13 ' A' ' 420' ' ' VAL . 37.3 Cg_endo -75.47 107.9 2.58 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 123.951 1.5 . . . . 0.0 110.586 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.878 ' HG ' HD11 ' A' ' 445' ' ' LEU . 12.4 mt -92.0 133.76 35.42 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.859 -1.151 . . . . 0.0 108.482 166.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.964 ' CG2' HG22 ' A' ' 398' ' ' VAL . 90.5 t -99.17 134.4 38.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 O-C-N 120.715 -1.241 . . . . 0.0 109.389 175.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' VAL . . . . . 0.925 ' CG1' HD11 ' A' ' 440' ' ' LEU . 34.9 t -115.1 137.77 47.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 C-N-CA 119.558 -0.857 . . . . 0.0 108.96 176.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 439' ' ' VAL . 2.9 m -122.01 160.07 24.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.409 -0.807 . . . . 0.0 109.687 -176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . 0.478 ' CB ' HD23 ' A' ' 440' ' ' LEU . 4.6 tt0 -135.7 133.15 37.79 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLY . . . . . . . . . . . . . . . 65.92 -124.82 26.75 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -168.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' SER . . . . . 0.491 ' O ' ' HA3' ' A' ' 410' ' ' GLY . 1.0 OUTLIER -111.45 11.96 21.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.053 -1.263 . . . . 0.0 111.109 -178.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -125.58 171.04 10.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.562 -1.336 . . . . 0.0 110.111 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . 0.85 ' HA ' HG12 ' A' ' 434' ' ' VAL . 56.4 t -89.5 134.24 29.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.877 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.925 HD11 ' CG1' ' A' ' 433' ' ' VAL . 1.2 pp -93.35 -21.87 19.29 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.6 175.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 1.003 ' HA3' HD22 ' A' ' 333' ' ' LEU . . . 170.06 176.7 39.86 Favored Glycine 0 N--CA 1.499 2.877 0 C-N-CA 118.897 -1.621 . . . . 0.0 110.959 169.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 1.032 HG21 HG23 ' A' ' 420' ' ' VAL . 47.4 t -107.86 141.7 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.055 -1.262 . . . . 0.0 109.802 172.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.677 HD11 ' HB1' ' A' ' 337' ' ' ALA . 81.0 mt -101.39 110.63 28.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.454 -0.779 . . . . 0.0 108.9 171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ALA . . . . . 0.606 ' HB2' HG21 ' A' ' 423' ' ' VAL . . . -91.58 118.85 30.98 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.998 -1.064 . . . . 0.0 109.739 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LEU . . . . . 0.878 HD11 ' HG ' ' A' ' 431' ' ' LEU . 1.1 mt -100.45 143.85 30.15 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . 0.454 ' HB2' ' OG ' ' A' ' 320' ' ' SER . 58.3 mttt -120.63 161.36 21.5 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.708 -1.245 . . . . 0.0 111.24 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -86.6 148.93 25.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.817 -0.552 . . . . 0.0 110.246 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ILE . . . . . . . . . . . . . 10.7 tp -115.87 153.91 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -0.873 . . . . 0.0 110.124 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.39 134.06 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 110.359 -176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -143.42 146.5 33.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 110.105 175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 118.0 -1.444 . . . . 0.0 109.582 -179.938 . . . . . . . . 0 0 . 1 stop_ save_